Bull Horn Holdings (BHSE) Shareholders Approve Coeptis Therapeutics Deal
by Marlena Haddad on 2022-10-26 at 4:59pm

Bull Horn Holdings Corp. (NASDAQ:BHSE) disclosed this afternoon that its shareholders have approved its combination with biopharmaceutical company Coeptis (OTC:COEP) in a special meeting held earlier today.

A total of 2,869,654 ordinary shares, or approximately 88.5% of Bull Horn’s outstanding public shares, were redeemed at today’s meeting. But, the SPAC had already faced previous redemptions of 4,258,586 public shares during a shareholder vote for a timeline extension back in April. This brings the total amount redeemed to 95.04% following today’s completion vote. As a result, BHSE will have approximately 371,760 public shares and $3.8 million remaining in its trust account following the redemptions.

Despite the high amount of redemptions, Bull Horn still expects the deal to be completed promptly following the satisfaction or waiver of the other conditions to the consummation of the business combination. The combined company is expected to trade under the symbol “COEP” once the deal is completed.

The parties initially announced their business combination on April 19. Wexford, Pennsylvania-based Coeptis is developing a pair of therapies designed to improve the efficacy of cancer treatments.


ADVISORS

  • Bridgeway Capital Partners served as financial advisors to Coeptis.
  • Meister Seelig & Fein LLP served as legal advisors to Coeptis.
  • Jones Trading served as financial advisor to Bull Horn.
  • Ellenoff Grossman & Schole LLP served as legal advisors to Bull Horn.
Recent Posts
by Nicholas Alan Clayton on 2024-04-24 at 8:07am

At the SPAC of Dawn Although the market has largely recovered from a negative stretch last week, the roller coaster is tilted back downward for Trump Media (NASDAQ:DJT), which slid -8% yesterday to $32.57 – one of its lowest points since closing with Digital World last month. Other SPACs and de-SPACs are having a more...

by Nicholas Alan Clayton on 2024-04-23 at 4:05pm

Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...

by Nicholas Alan Clayton on 2024-04-23 at 7:50am

At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...

by Nicholas Alan Clayton on 2024-04-22 at 3:01pm

With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...

by Nicholas Alan Clayton on 2024-04-22 at 7:51am

At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved